+49 711 500 989 80
deen

New platform optimizes selection of combination cancer therapies



New platform optimizes selection of combination cancer therapies

Researchers have developed a new computational tool to select optimal combination therapies for patients with cancer based on the co-occurring alterations in a given tumor.

Materials provided by University of Texas M. D. Anderson Cancer Center. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

27th September 2022

Rhombic lip implicated in origins of high-risk medulloblastoma

Read more
27th September 2022

How prostate cancer may begin

Read more
27th September 2022

Diets rich in refined fiber may increase liver cancer risk in some individuals

Read more